Behavioural weight management interventions in research studies and clinical practice differ in length, advice, frequency of meetings, staff, and cost. Few real-world programmes have published patient outcomes and those that have used different ways of reporting information, making it impossible to compare interventions and develop the evidence base. To address this issue, we have developed a core outcome set for behavioural weight management intervention programmes for adults with overweight and obesity. Outcomes were identified via systematic review of the literature. A representative expert group was formed comprising people with experience of adult weight management services. An online Delphi process was employed to reach consensus as to which outcomes should be measured and reported and which definitions/instruments should be utilised. The expert group identified eight core outcomes and 12 core processes for reporting by weight management services. Eleven outcomes and five processes were identified as optional. The most appropriate definitions/instruments for measuring each outcome/process were also agreed. Our core outcome set will ensure consistency of reporting. This will allow behavioural weight management interventions to be compared, revealing which interventions work best for which members of the population and helping inform development of adult behavioural weight management interventions. KEYWORDS adult behavioural weight management interventions, core outcome set, standardised reporting ---
| INTRODUCTION
Behavioural weight management interventions (BWMIs), known in the United Kingdom (UK) as tier 2 services, are the first line treatment for overweight and obesity [1] [2] [3] [4] . International guidelines, including those of The National Institute for Health and Care Excellence (NICE) 1 , Scottish Intercollegiate Guidelines Network (SIGN) 2 , and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society 3 , outline the intervention components to be included in a behavioural weight management programme for adults. These components, which include calorie restriction, increased physical activity and behavioural change support, have proven efficacy in randomised controlled trials 3 . However, their implementation in practice is inconsistent. Indeed, mapping exercises in Scotland 4 and England 5 revealed wide variation in adult weight management services with regard to inclusion criteria, referral routes, delivery format, programme length and cost, despite the single-payer health care system. Furthermore, few adult BWMIs have published outcome data and where these data are published, results are often poor with low levels of programme completion and "success," with a lack of longer term outcomes 6, 7 .
When developing the guidance, "Weight management: lifestyle services for overweight or obese adults" 1 in 2014, NICE identified a number of evidence gaps. These included reliance on studies with short follow-up, collection of data at limited time points, small sample sizes, demographic samples that limit the ability to generalise, nonreporting of reasons for people dropping out and lack of evidence regarding the effect of population characteristics, such as age, gender, and socio-economic status, on the effectiveness of a service. NICE specifically mentioned "variable outcome definitions" used in the clinical trials, which formed the supporting systematic review and meta-analysis, as a major barrier to developing evidence-based guidance. As a result, they were left with many evidence gaps including "a lack of trials directly comparing lifestyle weight management programmes in the UK" and "a general lack of evidence on which specific components of a lifestyle weight management programme ensure effectiveness." This lack of an evidence base from both clinical trials and real-world services means that it is not possible to issue clear guidance as to which services are cost effective for which population groups.
Public health bodies in the United Kingdom have made efforts to try and address this issue; Public Health England (PHE) 8 created a standard evaluation framework (SEF) for weight management programmes 9 . However, PHE was unable to analyse data from real world interventions due to the heterogeneity of reporting, suggesting further guidance is required. This heterogeneity can be exemplified by reporting of weight loss, which included number of kilograms lost, percentage weight loss, average number of completers achieving 5% weight loss, and body mass index (BMI) 5 . With regard to clinical trials, evidence suggests similarly heterogeneous reporting of outcomes 7 .
It is acknowledged that the provision of treatments for obesity is severely limited across the world, [10] [11] [12] [13] [14] and large gaps in the evidence of effectiveness may be contributing to this. An improved evidence base would allow intervention programmes to be commissioned and funded by health systems with the confidence of effectiveness. There is an urgent need to gain consensus on standardised outcome reporting to allow better comparison and meta-analysis of interventions to be performed across both real world and trial interventions. Therefore, the specific aim of this study was to use Delphi methodology to gain expert consensus opinion on the core outcomes that should be reported from BWMIs in real-world clinical practice as well as within research studies and on the outcome definitions/outcome measurement instruments that should be used in their evaluation.
Core outcome set (COS) development has an established methodology, 15 and COS represent the minimum that should be reported in all clinical trials of a specific condition, while also being suitable for observation research and audit; their use in clinical trials is supported by the UK National Institute of Health Research (NIHR) 16 as it allows trial results to be easily compared and combined. However, the development of a COS does not imply that research outcomes should be restricted to only those included in the COS. The development of these core outcome and definition/instrument sets for BWMIs will ensure more consistency in the measurement of the effectiveness of weight management services, leading to a better evidence base from which to identify which services are effective across a range of settings.
| METHODS

| Ethics
Ethical approval for this study was received from the University of Glasgow College of Medical, Veterinary and Life Sciences Ethics Committee.
The project has been registered with the COMET (Core Outcome Measures in Effectiveness Trials) Initiative (http://www.comet-initiative.org/studies/details/1056), and a detailed methodology has been reported previously 17 . In reporting the development of our COS, we have adhered to the COS-STAR (Core Outcome Set-STAndards for Reporting) Statement (Table S1) 18 .
| Identification of outcomes
In order to develop a COS, a comprehensive list of outcomes for reporting from BWMIs was generated. These outcomes were identified following review of studies included in the systematic review, "The clinical effectiveness of long-term weight management schemes for adults" by Hartmann-Boyce et al 7 , conducted during the development of NICE guidance 1 . This review was updated to cover the time period 1 November 2012, until 30 September 2017, using the same inclusion criteria (inclusion criteria and additional studies are outlined in Section S1). Both primary and secondary outcomes from studies were identified by two independent researchers and entered into a spreadsheet. Additionally, the PHE SEF 9 , minimum dataset, 19 and key performance indicators (KPI) document 20 were reviewed, again by two independent researchers, and any supplementary outcomes added to the aforementioned spreadsheet. Of note, the PHE SEF 9 was developed following focus group work with a wide range of stakeholders, including weight management staff, primary care staff, academics, commissioners, and policy makers, and has been refined over two versions from 2009 to 2018.
| Identification of outcome measurement instruments/outcome definitions
Analyses of studies identified during the systematic review by Hartmann-Boyce 7 and our updated search (Section S1) allowed instruments and definitions for selected outcomes to be added to the data extraction spreadsheet by two independent researchers. This list was then examined by all study investigators and further suitable instruments/definitions added.
| Participants
The core outcome and instrument set was developed by means of consensus from an expert group, recruited as outlined previously 17 and selected based on our sampling framework (Section S2) to ensure a representative sample and a pragmatic and patient-centred COS. All experts recruited were from the United Kingdom.
For the stage 1 (outcome selection) Delphi process, agreement to participate was obtained from 10 members of the public with experience of NHS, local authority, or commercial weight management programmes in the United Kingdom, 10 academics/policy makers/commissioners working in weight management, 10 weight management staff involved in delivering a lifestyle weight management programme for adults (without significant policy involvement), and 10 primary care staff with experience of referring patients to weight management programmes (Table S2) .
With regard to members of the public, in line with the sampling framework, six of 10 had experience of commercial BWMIs (60%), six of 10 were of working age (60%), and four of 10 were male (40%) ( Table S2 ). The 10 members of the public represented nine different UK counties (six Scottish counties and three English counties).
As per the sampling framework, nine of the 10 academics/policy makers/commissioners were from England (90%), four of the 10 were academics (40%), three of the 10 were policy makers (30%), and three of the 10 were commissioners (30%) ( Table S2 ).
Seven of the 10 primary care staff (70%) and eight of the 10 weight management staff (80%) selected were from England (Table S2) .
For the second Delphi process (stage 2, instrument/definition selection), 20 academics/policy makers/commissioners and 20 weight management staff were invited to participate and included those who had successfully completed all three rounds of the stage 1 Delphi. The stage 2 Delphi involved reading papers, looking at metrics and assessing validity of instruments/questionnaires. With such a level of knowledge and expertise required, members of the public and primary care staff were not involved in this stage of the Delphi process.
Broadly in keeping with our sampling framework, 16 of the 20 stage 2 academics/policy makers/commissioners group members were from England (80%), 11 of the 20 were academics (55%), four of the 20 were policy makers (20%), and five of the 20 were commissioners (25%) ( Table S3 ).
With regard to weight management staff, as per our sampling framework, 14 of the 20 group members were from England (70%) ( Table S3 ).
The research team conducting the study consisted of a clinical trialist/obesity physician, a health psychologist/trialist in weight management and behaviour change, a public health researcher/specialist advisor to PHE Obesity Team, and a researcher in cardiometabolic medicine.
| Delphi survey
Delphi methodology was used to gain consensus from the expert group. Two separate Delphi processes (stage 1 and stage 2) were conducted using an online questionnaire system (www.clinvivo. com). Each Delphi process ran over three sequential rounds with the same group of participants ( Figure 1 ). For both the outcome selection and outcome measurement/outcome definition selection (stage 1 and stage 2) Delphi processes, those who completed a questionnaire in round 1 were eligible to participate in round 2, and those who completed round 2 were eligible to participate in round 3. In short, in order for the expert group to reach consensus, only those completing a given questionnaire were eligible to complete the subsequent questionnaire.
The stage 1, outcome selection Delphi, asked each expert to score the importance of an outcome measure for use in BWMI outcome reporting. The scale ran from 1 to 9 with 1 to 3 indicating that the outcome was unimportant, 4 to 6 indicating that it was neither unimportant nor important ("unsure"), and 7 to 9 indicating that it was important. During rounds 1 and 2, participants were also given the opportunity to suggest additional outcomes. All outcomes, excluding any rated unimportant by consensus (see Section 2.6) and including any appropriate new outcomes, were carried forward to the subsequent round (Figure 1 ).
During the stage 2, definition/instrument selection Delphi, experts were asked to score the appropriateness of outcome definitions and instruments for measurement of outcomes. Again, this was done using a 1 to 9 scale with 1 to 3 indicating that the definition/instrument was inappropriate, 4 to 6 indicating that it was neither appropriate nor inappropriate ("unsure"), and 7 to 9 indicating that it was appropriate. During rounds 1 and 2, participants were once more given the chance to suggest additional instruments/definitions. As for stage 1, all instruments/definitions, excluding any rated unimportant by consensus (see Section 2.6) and including any new instruments/definitions, were carried forward to the subsequent round ( Figure 1 ).
For both stage 1 and stage 2 of the Delphi process, participant responses were summarised and fed back in subsequent rounds with participants receiving their own score and the expert group mean score for each outcome or instrument/definition. Following round 3 of the stage 1 Delphi, consensus on the outcome set size and importance of outcomes was used to develop an outcome set. Similarly, following round 3 of the stage 2 Delphi process, a final instrument set matched to the COS was formed based on the consensus. In areas where there was no consensus, the study team adjudicated, taking account of free text comments.
| Statistical analysis
As outlined in our published protocol 17 , the Research and Development (RAND)/University of California Los Angeles (UCLA) appropriateness method 21 was used to assess disagreement and importance/appropriateness (and thus define consensus). This involved calculating the mean score, the median score, the interpercentile range (IPR, 30th and 70th), and the inter-percentile range adjusted for symmetry (IPRAS), for each item being rated. For a given item, disagreement was indicated when the ratio of IPR to IPRAS (the disagreement index) was greater than 1.
Importance/appropriateness was assessed simply as whether the mean and/or median rating fell between 1 and 3 (unimportant/inappropriate), 4 and 6 (unsure), or 7 and 9 (important/appropriate).
At the end of each Delphi round, the mean and median ratings were determined for individual outcomes/instruments and the distribution of ratings summarised ( Figure 1 ). Free text comments were analysed qualitatively, creating a narrative summary of responses based on the nine domains used in the questionnaire.
| RESULTS
| Outcome selection
A list of 94 outcomes for reporting from BWMIs was generated from our review of the literature and systematic review process.
The 94 outcomes were mapped across appropriate domains by consensus of three members of the research team at a face to face meeting. The domains followed section headings used in the PHE This resulted in a 148-item questionnaire with 75 outcomes for reporting at baseline and 73 outcomes at the end of the intervention.
The stage 1, round 1, Delphi questionnaire can be seen, as it appeared to study participants, in Section S3. Of the 40 invited participants, 38 completed responses were received for the stage 1, round 1 Delphi questionnaire, representing a 95% response rate (100% of members of the public, academics, policy makers, commissioners, and weight management staff and 80% of primary care staff).
One hundred two of 148 outcomes were rated as important by the expert group (median rating greater than or equal to 7) with no evidence of disagreement between group members. The 102 outcomes rated as important were carried forward to the round 2 Delphi questionnaire (Table S4 ).
The remaining 46 outcomes were rated as being either unimportant or unsure (neither important nor unimportant) by the expert group (median rating less than or equal to 6.5, Table S4 . For all but one outcome (1 month follow-up time point, disagreement index greater than 1), expert group members were again in agreement (Table   S4 ). Outcomes rated as unimportant or unsure were not carried forward to round 2 (Table S4 ).
During the round 1 questionnaire, 19 additional outcomes were suggested by expert group members (Table S5 and Section S4). The study team decided that four of the 19 suggested outcomes were unique and valid and would therefore be carried forward to the round 2 Delphi (Table S5) , giving a total of 109 outcomes to be rated in this round (three of the four additional outcomes were to be rated for reporting at both first visit and end of programme).
| Round 2
The stage 1 round 2 Delphi questionnaire can be seen, as it appeared to study participants, in Section S5.
Thirty-three of 38 completed questionnaires were received, representing an 86.8% response rate (100% of academics, policy makers, and commissioners; 90% of members of the public; and 62.5% of primary care staff).
Following analyses of round 2 questionnaires, 87 of 109 outcomes were found to have been rated as important by the expert group (median rating greater than or equal to 7). The remaining 22 outcomes were rated as unsure (median rating less than or equal to 6.5). No outcomes were rated as being unimportant, and no disagreement was evident between group members for any of the ratings (Table S4 ). Participants' free text comments from round 2 can be seen in Section S6. No additional outcomes were suggested during this round.
In order to enable development of an outcome set of a manageable/practical size, the study team decided that outcomes would be split into three categories (core, optional, and for exclusion) based on both their mean and median rating. Note. Outcomes rated by the expert panel as being most important with a mean rating greater than 7 and a median rating greater than or equal to 8 were designated as core for measurement and reporting by BWMIs.
Abbreviations: BMI, body mass index; QoL, quality of life. a Mean scores were not greater than 7 and/or median scores were not greater than or equal to 8, but outcomes are considered protected characteristics.
b New outcome added to ensure a comprehensive core outcome set.
The 14 outcomes rated as most important with a mean rating greater than 7 and a median rating greater than or equal to 8 were designated as core for measurement and reporting by BWMIs (Table 1 ). Of these 14 outcomes, four were to be measured and reported at both first visit and at the end of the programme. An additional five outcomes (gender, ethnicity, deprivation category, learning disability, and physical disability) were then added to the core category. While these additional outcomes were rated as being important by the expert group, mean scores were not greater than 7 and/or median scores were not greater than or equal to 8. However, these outcomes are considered protected characteristics 22 and therefore should be reported in government-funded projects. Finally, an entirely new outcome, "formally diagnosed with a mental health condition,"
was added to the core category as it was felt that its inclusion was At follow-up High future risk of diabetes (impaired fasting glucose, impaired glucose tolerance, raised HbA1c Levels)
7
At follow-up Binge eating disorder 6.5 7
At baseline High cholesterol/lipids 6.5 7
At baseline Importance of weight loss 6.5 7
At baseline Disordered eating 6.5 7
At follow-up Blood pressure 6.5 7
At follow-up Self esteem 6.5 7
At follow-up Reach 6.5 7
Follow-up time point 3 mo 6.5 7
At baseline Cardiovascular risk a 6.4 7
At baseline Self-confidence a 6.4 7
At baseline Self-esteem a 6.4 7
At baseline Blood pressure a 6.2 7
Note. Outcomes rated by the expert panel as being reasonably important with a mean rating greater than or equal to 6.5 and less than or equal to 7.1, and a median rating less than or equal to 8 were designated as being optional for measurement and reporting by BWMIs.
Abbreviation: HbA1c, haemoglobin A1c. a Mean scores less than 6.5 for the first visit/baseline time point but corresponding follow-up time point scores meet rating criteria for the optional list. 20 . Therefore, the core set included 20 outcomes for measurement and reporting by BWMIs (Table 1) .
Twenty-two outcomes were rated as being reasonably important with a mean rating greater than or equal to 6.5 and less than or equal to 7.1, and a median rating less than or equal to 8. These outcomes were designated as being optional for measurement and reporting by BWMIs. Of these 22 outcomes, nine were to be measured and reported at both first visit and at the end of the programme. Of note, for four of these nine (blood pressure, cardiovascular risk, self-esteem, and self-confidence), the mean rating was slightly less than 6.5 for the first visit time point. However, with the corresponding end of programme/follow-up time point meeting the rating criteria for the optional list, it was felt that these four outcomes should be included in order to ensure the follow-up measurement was meaningful with a baseline value to compare it to. As such, the optional set included 22 outcomes for measurement and reporting by BWMIs ( Table 2) .
The 37 outcomes rated as being least important by the expert panel (mean less than 6.5 and median less than or equal to 7) were grouped together in the "for exclusion" category. These outcomes would not be recommended for measurement and reporting by BWMIs unless participants gave a convincing argument for their inclusion during the round 3 Delphi (Table 3 ).
| Round 3
The stage 1 round 3 Delphi questionnaire can be seen, as it appeared to participants, in Section S7.
Prior to commencing the questionnaire, it was explained to participants that the results of the first 2 rounds of Delphi questionnaires had allowed lists of outcomes, which would be considered core and optional for reporting by BWMIs to be made. It was explained that a list of outcomes to be excluded had also been drafted and that we would not recommend these outcomes be measured by BWMIs. Participants were informed that this would not mean that a weight management service could not measure these excluded outcomes should they wish to, but that measuring and reporting the other outcomes should be considered a higher priority.
Participants were asked to study the lists and indicate whether they agreed with the findings of the expert panel. They were advised that should they disagree with the findings, they would have the opportunity to express their disagreement and make suggestions as to any changes they felt should be made. It was made clear that if a number of participants were to express similar opinions, the lists would be altered appropriately.
The 33 expert group members who completed the round 2 questionnaire were invited to participate in the round 3 Delphi. All 33 members completed questionnaires, representing a 100% response rate for round 3. With 33/40 participants completing all three rounds of the stage 1 Delphi process, the overall response rate for stage 1 was 82.5% (100% of academics, policy makers, and commissioners;
90% of weight management staff and members of the public; and 50% of primary care staff).
Following our analyses of the completed round 3 questionnaires, 25 of 33 participants (75.8%) indicated that they were in agreement with the core and optional outcome sets. Comments from the eight participants who were not in agreement are included within Section S8. Having given these comments due consideration, the study team were of the opinion that no changes were required to the core or optional outcome sets (Tables 1 and 2) prior to the stage 2 (instrument selection) Delphi process.
As outlined in Table 1 , the final list of core outcomes included "weight" (at baseline and follow-up), "completion" (at follow-up),
"attendance" (at follow-up), "BMI" (at baseline and follow-up), "diabetes status" (at baseline and follow-up), "participant satisfaction" (at Note. Outcomes rated by the expert panel as being least important with a mean rating less than 6.5 and a median rating less than or equal to 7 were designated as being "for exclusion" and would therefore not be recommended for measurement and reporting by BWMIs, unless participants gave a convincing argument for their recommendation during the round 3 Delphi.
Abbreviation: NAFLD, nonalcoholic fatty liver disease. (Table 2) .
With regard to outcomes for exclusion, 22 of 33 participants (66.7%) indicated that they were in agreement. Comments from the 11 participants who were not in agreement are included within Section S8. Again, following due consideration, the study team decided that no excluded outcomes should be retained/added to the optional outcome list prior to the stage 2 Delphi. The final list of outcomes for exclusion following the stage 1 Delphi process was, therefore, as outlined in Table 3 .
| Outcome measurement instrument selection
By reviewing the trials identified by Hartman Boyce et al 7 and our update, definitions and instruments that could be used for measurement of the core and optional outcomes selected during the stage 1 Delphi process were listed (Table S6 ). Further, suitable definitions and instruments for these outcomes were added based on the study team's knowledge (Table S6 ).
For simplification, outcomes for which the definition or instrument was well established or where only a single possible option was available were not included in the stage 2 process, while some outcomes within the optional outcomes set were combined; "binge eating disorder" was combined with "disordered eating," and, although slightly different concepts, "self-esteem" and "self-confidence" were combined.
Furthermore, an outcome relating to the presentation of results was added to the core set for inclusion in the stage 2 Delphi. Due to having specific instruments for their measurement, "learning disability QoL score" and "physical disability QoL score" outcomes were also included in the core set. In addition, as it had been borderline for inclusion based on rank, required only a yes/no answer with no patient burden and was specifically mentioned in NICE guidance 1 as a question for future research, the "repeat referrals" outcome (mean rating of 7.1 and median rating of 7) was moved from the optional to the core outcomes list (Table S6 ).
| Delphi survey-Stage 2/outcome measurement instrument selection
| Round 1
The stage 2 round 1 Delphi questionnaire can be seen, as it appeared to study participants, in Section S9. Documents 1 to 8 referred to within the questionnaire were provided in parallel and included full descriptions of all instruments and, where possible, peer-reviewed publications regarding their validity [23] [24] [25] [26] .
Thirty-three of 40 completed questionnaires were received, representing an 82.5% response rate (85% of weight management staff, 82% of academics, 80% of commissioners, and 75% of policy makers). Note. Fifty-six of 163 definitions/instruments were rated as appropriate by the expert group (median rating greater than or equal to 7) with no disagreement between experts. One hundred seven definitions/instruments were rated as unsure (median rating less than or equal to 6.5). The expert group was in agreement (disagreement index less than 1.0) for 104 of these 107 items. Following analyses of completed questionnaires, 56 of 163 definitions/instruments were found to have been deemed appropriate by the expert group (median rating greater than or equal to 7) with no evidence of disagreement between expert panel members (Table 4 ).
The remaining 107 definitions/instruments were rated as unsure (neither appropriate nor inappropriate) by the expert group (median rating less than or equal to 6.5). The expert group were in agreement (disagreement index less than 1.0) for 104 of these 107 items (Table 4 ).
For all but eight outcomes, round 1 scores allowed discrimination between the definition/instrument options provided. In the majority of instances, options were selected for reporting if they were rated as important (median score greater than or equal to 7). For outcomes where none of the definition/instrument options were rated as important (learning disability QoL score, high cholesterol/lipids, high future risk of diabetes, and self-confidence and self-esteem), the highest scoring of the options deemed unsure were selected (Table 4 ). In cases where one of many definition/instrument options for an outcome received a much higher rating than the others, this option was selected for reporting and the lower scoring options were discarded despite some being rated as important (median greater than or equal to 7). An example of this can be seen for the "attendance" outcome where item 11.1, "mean % of core/mandatory sessions attended by participants" (median value of 8 and mean value of 7.9) was selected for reporting and items 11.3, "% of participants attending greater than or equal to 80% of core/mandatory sessions," and 11.4, "% of participants attending greater than or equal to 70% of core/mandatory sessions," (median values of 7 and mean values of 6.8 and 6.5, respectively) were discarded. Conversely, for the "representativeness" outcome, item 28.7, "based on other criteria" was included for reporting despite being rated as unsure (median value of 5). This was because this item requested suggestions for additional measures, and one of the free text suggestions provided (geographical location) was deemed suitable for reporting. Participants' free text comments from round 1 can be seen in Section S10. Thirty-five definitions/instruments relating to the eight outcomes listed above were carried forward to the round 2 Delphi questionnaire ( Table 4 ).
| Round 2
The stage 2 round 2 Delphi questionnaire can be seen, as it appeared to study participants, in Section S11. Within this questionnaire, participants were required, for each of the eight included outcomes, to rank the options provided in terms of their appropriateness for use or to select a single preferred definition/instrument. As stated, 35 definitions/instruments were carried forward from the stage 2, round 1 questionnaire. However, participants were asked to consider 31 options during the stage 2 questionnaire, the result of baseline and follow-up time points being combined where possible, and the addition of options representing a combination of definitions/instruments for a given outcome (Section S11).
The 33 expert group members who completed the stage 2, round 1 questionnaire were invited to participate in round 2 and 29/33 completed questionnaires were received, representing an 88% response rate (100% of weight management staff, 88.9% of academics, 66.7% of policy makers, and 50% of commissioners).
As shown in Section S11, participants were asked to rank seven definitions for measuring and reporting weight loss at follow-up in order of their appropriateness for use. Results are summarised in Similarly, the expert panel ranked five options pertaining to the presentation of results at follow-up in order of their appropriateness for use (Section S11). Results are shown in Table 6 . Based on mean and median ratings, item 7.5 (combining both items 7.2 and 7.3) was selected to be carried forward to round 3.
For the remaining six outcomes (completion, participant satisfaction, cost effectiveness, overall measure of comorbidity, depression, and importance of weight loss), experts were instructed to select the most appropriate definition/instrument for measurement and reporting from the options provided (Section S11). Selection frequency for each option was determined, and the option selected most frequently for a given outcome was then carried forward (Table 7) , the exceptions being "participant satisfaction" and "overall measure of comorbidity." For the former, experts' comments and scores indicated that neither of the suggested instruments (questionnaires) was ideal.
Therefore, it was decided that both instrument options would be retained for round 3, but the expert panel would be informed that alternative methods to measure this outcome could be used. In the case of "overall measure of comorbidity," the majority of experts indicated that they had insufficient knowledge of the instruments and were therefore unable to select which would be most appropriate for use. Consequently, the most frequently selected of the remaining options, mean Edmonton Obesity Scale Score (EOSS) score, was selected to be carried forward to round 3.
Participants' free text comments from round 2 can be seen in Section S12.
| Round 3
Experts were asked to study the final list of selected by stating that they partially accepted the results rather than rejecting them outright (Section S14). Comments suggested that the main concern was related to measures of diabetes status with participants questioning whether there was capacity in services to perform the necessary medical tests, who would fund these tests and whether performing them would place an unreasonable burden on weight management staff (Section S14). However, with the vast majority of the expert group in agreement with the results and free text comments of those not in agreement failing to provide a convincing argument for alteration of the final definition/instrument list, our core and optional outcome and definition/instrument sets were finalised and are included as Table 8 . As shown, "outcomes" within both sets were designated as being either process outcomes, outcomes, or guidance for presentation of results (Table 8 ).
| DISCUSSION
A COS is an agreed minimum set of outcomes for measuring and reporting for a specific area of health. COSs have been developed across a range of health areas, including bariatric and metabolic surgery 27 . While a recent study obtained expert panel consensus on recommendations for standard baseline assessment in medical obesity Note. Participants were asked to rank seven definitions for measuring and reporting weight loss at follow-up in order of their appropriateness for use. Based on mean and median ratings, all 4 potential definitions (items 3.1, 3.2, 3.3, and 3.4) were selected to be carried forward to the final definition/instrument selection Delphi (stage 2, round 3). Note. Participants were asked to rank five options pertaining to the presentation of results at follow-up in order of their appropriateness for use. Based on mean and median ratings, 2 items (items 7.2 and 7.3) were selected to be carried forward to the final definition/instrument selection Delphi (stage 2, round 3). management clinics 28 , to our knowledge, the study described herein is the first of its kind to develop a COS and corresponding definition/instrument set for BWMIs for adults with overweight and obesity. This is much needed in order to standardise reporting which, in turn, will lead to a better evidence base and improvements in weight Note. Participants were instructed to select the most appropriate definition/instrument for measurement and reporting from the options provided for each outcome. Selection frequency for each option was determined and the option selected most frequently retained for the stage 2, round 3 Delphi. Participants' comments and scores indicated that neither of the suggested instruments was ideal. Therefore, no instrument was selected. These two options will be given as suggestions but other methods could be used. b The majority of participants indicated that they had insufficient knowledge of the instruments and were therefore unable to select which would be most appropriate for use. Consequently, the most frequently selected of the remaining options, mean EOSS score, was retained for the stage 2, round 3. Whether a participant has been referred to a specialist management service (tier 3 or 4) by a GP or tier 2 weight management service after failing to lose the required amount of weight via a lifestyle weight management programme or due to a condition needing specialist input.
• % of participants
Repeat referrals (real world evaluations only)
Whether a participant has been referred to the weight management service on more than one occasion.
• % of participants previously referred to the service, not necessarily having attended any sessions)
• % of participants answering yes, having previously attended at least 1 weight management session (Continues) • % of participants with type 2 diabetes mellitus (based on selfreport, case record, or blood test)
• Mean change in HbA1c levels of those participants with T2DM
Quality of life (QoL) score A measure of the general well-being of participants.
• Mean EQ-5D-5L scores of participants 
Core Outcome Set
Reach (% eligible population who are referred to/take up weight management service)
The percentage of the eligible population (people who are overweight or obese within that particular geographical area) referred to the weight management service.
For a specific population subgroup of concern, what % of that population has been referred to/ attended the weight management service. Local data (eg, Quality and Outcomes Framework) can be used to obtain prevalence rates. Population subgroups of interest:
• Age <30
• Male
• People with T2DM
• ensured that opinions expressed by members of the public were given equal weighting to those expressed by professionals. However, throughout the majority of the Delphi process, experts from each of the four groups were observed to be in agreement as to the importance of outcomes for reporting from BWMIs and the appropriateness of definitions/instruments for their measurement. In addition, retention rates for our experts were high throughout the Delphi process with 82.5% completing stage 1 (outcome selection) and 67.5% completing stage 2 (instrument selection). These high retention rates can be attributed to the nature of our recruitment and selection processes. In order to select a panel based on our sampling framework, potential experts were asked to provide information on geographical location etc. Those responding appropriately in a timely manner demonstrated their willingness to participate and their commitment to the process and were therefore considered for Delphi expert panel selection. Those failing to respond to our requests were deemed unlikely to fully engage with the Delphi process and were not included in the selection process.
Experts agreed on a final core outcome and corresponding definition/instrument set consisting of 24 items, which were designated as either processes, outcomes, or guidance for presentation of results.
As we may have expected, weight, BMI, attendance, completion, and cost effectiveness featured in the final COS and follow-up time points of 12 and 24 months were stipulated. Experts also agreed that an additional optional COS was necessary. This included 19 items, again designated as either processes, outcomes, or guidance for presentation of results, which BWMIs could report should they wish to do so. Both the core and optional outcome sets were observed to include outcomes relevant to patients, clinicians, and commissioners/policy makers, reflecting the composition of our expert group.
While the vast majority of experts were in agreement with the final outcome and corresponding definition/instrument sets, some issues were raised by weight management staff with regard to the feasibility of the outcomes. With these concerns in mind, it should be noted that the measurement of each outcome is not considered mandatory for every patient/participant; the outcome sets are merely intended to serve as a guide for planned evaluations. A lack of funding and requirement for evaluation is a key issue for real-world services. The majority of outcomes in the COS are generally measured during routine care, but it is recognised that certain outcomes will prove more challenging for weight management staff, an example being the determination of haemoglobin A1c (HbA1c) levels if linking to routinely measured test results is not possible. In addition, information on longer term outcomes (at 12 and 24 months) is likely to be difficult to obtain given the relatively short duration of the majority of BWMIs.
Furthermore, those participants who regain weight are less likely to provide weight details or return to be weighed at a later stage. As such, research is needed in order to improve linkage to health records and to determine how best to persuade patients/participants to • % of participants with disordered eating (defined as per service)
• Change in % of participants with disordered eating (defined as per service)
Prescription of anti-obesity medication
The number of participants taking drugs to help reduce or control their weight
• % of participants on any antiobesity medication (total and by class/medication)
• Change in % of participants on anti-obesity medication (total and by class/medication) Guidance For Presentation of Results (Optional Outcome Set)
3-mo follow-up
Reporting outcomes 3 mo after starting the weight loss programme 6-mo follow-up Reporting outcomes 6 mo after starting of the weight loss programme 18-mo follow-up Reporting outcomes 18 mo after starting the weight loss programme
Note. The expert group agreed on a final core outcome and corresponding definition/instrument set consisting of 24 items. Twelve of these items were designated as processes, eight were designated as outcomes, and four were designated as guidance for presentation of results. Experts agreed on an optional outcome set consisting of 19 items; five processes, 11 outcomes, and three items relating to presentation of results. a These items are considered "protected characteristics" and therefore, in keeping with government guidelines, have been included in our core outcome set. These items are more relevant for real world services which are required to report such items to higher authorities. As such, these items are only core or mandatory for reporting when required in real life. engage with longer term outcomes 1 , perhaps by digital means, such as blue tooth scales or mobile apps. There is also a need for commissioners to consider the benefits of evaluation at the point of commissioning a service and ensuring that the service is funded sufficiently in order to gain meaningful insights 30 .
This study was, of course, restricted to the United Kingdom. This is due to BWMIs and their settings within health services being fairly country-specific. For example, in France and the Netherlands, there is no health insurance funding of BWMIs, and in the United States of America (USA), obesity services are tertiary, combining behavioural programmes with medication and bariatric surgery. Instruments can also be country-specific due to differences in language and health economic models, for example. In addition, "international" studies are often tokenistic, including only a small percentage of participants from outside the country in which the study is set. Within the "international" BARIACT study for example, the vast majority of professionals (95.2%) and patients (95.6%) participating were from the United Kingdom 27 . Our preference was to develop a COS with a balanced stakeholder group using a sampling framework to ensure wide representation; to do this on a truly international scale would be impossible. Consequently, if used in an international context for trials or real world services, our core outcome and definition/instrument set may require further adaptation. Therefore, the next step may be to undertake international validation of the COS. This could involve consensus meetings with professionals and patients in other countries.
In conclusion, this study has used internationally recognised methodology to develop a COS for BWMIs. Its widespread adoption by both clinical trialists and weight management programmes will improve the quality of data from research studies and real-life services, thus improving the evidence base and weight management provision.
